Skip to main content
Joel Gelfand, MD, Dermatology, Philadelphia, PA, Hospital of the University of Pennsylvania

JoelMGelfandMD

Dermatology • Philadelphia, PA

Professor of Dermatology and Epidemiology (with tenure), Perelman School of Medicine

Join to view full profile

Dr. Gelfand is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Gelfand's full profile

Already have an account?

Summary

  • Joel M. Gelfand MD MSCE is Professor of Dermatology and Epidemiology (with tenure) at the University of Pennsylvania’s Perelman School of Medicine. He is also Vice Chair of Clinical Research, Medical Director of the Dermatology Clinical Studies Unit, and Director of the Psoriasis and Phototherapy Treatment Center. He is a nationally and internationally recognized expert in psoriasis, clinical epidemiology, drug safety, and clinical trials. Dr. Gelfand is the author of over 260 scientific publications, editorials, reviews, and text book chapters (cited over 18,000 times, H index 60) which appear in journals such as JAMA, BMJ, European Heart Journal, Annals of Rheumatic Disease, JAMA Dermatology, JAAD, and the JID. He is the recipient of the American Skin Association’s Psoriasis Achievement Award, PENN’s New Investigator Marjorie Bowman Award and the Lady Barbara Colyton’s Award for Autoimmune research, Penn’s Department of Biostatistics and Epidemiology’s epidemiology teaching award, NPF’s inaugural award for scientific achievement, and is an elected member of the American Society for Clinical Investigation. He has given over 10 named lectureships and keynote addresses including the Society for Investigative Dermatology’s Eugene M. Farber lecture and the American Academy of Dermatology’s Marion B. Sulzberger lecture. He has received grant support from NIH, FDA, PCORI, the Dermatology Foundation, the American Skin Association, the National Psoriasis Foundation, and numerous pharmaceutical companies to support his independent research program. The overarching goal of his research and clinical practice is to improve psoriasis patient outcomes in the skin and joints, while lowering the risk of diabetes, CV disease and mortality.

Education & Training

  • University of Pennsylvania Perelman School of Medicine
    University of Pennsylvania Perelman School of MedicineMSCE, Clinical Epidemiology, 2001 - 2003
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Dermatology, 1999 - 2002
  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalInternship, Internal Medicine, 1998 - 1999
  • Harvard Medical School
    Harvard Medical SchoolClass of 1998, MD, Magna Cum Laude
  • Tufts University
    Tufts UniversityBS, Biology and Community Healthy, Summa Cum Laude, 1989 - 1993

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2000 - 2024
  • American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • Lady Barbara Colyton Prize for autoimmune research University of Pennsylvania Perelman School of Medicine, 2019
  • Outstanding Scientific Achievement National Psoriasis Foundation, 2017
  • Outstanding educator in psoriatic disease National Psoriasis Foundation, 2017
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Prevalence of Dermatitis Herpetiformis Within the iCureCeliac Patient-Powered Research Network—Patient Characteristics and Dietary Counseling  
    Joel Gelfand, MD, JAMA Dermatology
  • Association Between Early Severe Cardiovascular Events and Ustekinumab Treatment?  
    Joel M Gelfand, Erica D Dommasch, JAMA Dermatology
  • Evaluation of the Dermatology Life Quality Index Scoring Modification, the DLQI‐R Score, in Two Independent Populations  
    J Barbieri, J M Gelfand, The British Journal of Dermatology
  • Join now to see all

Lectures

  • Prevalence of Dermatitis Herpetiformis Within the iCureCeliac Patient-Powered Research Network—Patient Characteristics and Dietary Counseling 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019
  • Prevalence of Dermatitis Herpetiformis Within the iCureCeliac Patient-Powered Research Network—Patient Characteristics and Dietary Counseling 
    Global Academy for Medical Education (Elsevier), Maui, Hawaii - 2/10/2013
  • Prevalence of Dermatitis Herpetiformis Within the iCureCeliac Patient-Powered Research Network—Patient Characteristics and Dietary Counseling 
    National Psoriasis Foundation, Chicago, Illinois - 10/13/2012

Press Mentions

  • COVID-19 and Psoriasis: Is There a Link?
    COVID-19 and Psoriasis: Is There a Link?May 4th, 2023
  • Analysis Identifies Gaps in CV Risk Screening of Patients with Psoriasis
    Analysis Identifies Gaps in CV Risk Screening of Patients with PsoriasisApril 3rd, 2023
  • Targeting Specific Lipid Metabolic Pathway Linked to Reduced Psoriasis Risk
    Targeting Specific Lipid Metabolic Pathway Linked to Reduced Psoriasis RiskFebruary 2nd, 2023
  • Join now to see all

Grant Support

  • A Trial To Determine The Effect Of Psoriasis Treatment On Cardiometabolic DiseaseNational Heart, Lung, And Blood Institute2012
  • The Risk Of Myocardial Infarction In Patients With PsoriasisNational Heart, Lung, And Blood Institute2009–2012
  • Comparative Effectiveness Of Biologics For PsoriasisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2009–2010
  • Investigating The Risk Of Lymphoma In Psoriasis PatientsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2004–2008
  • Surrogate Markers Of Complete Venous Ulcer HealingNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2001–2002

Professional Memberships

Hospital Affiliations

External Links

Dr. Joel Gelfand, Dr. Joel Gelfand, MD, Dr. J Gelfand, Dr. Joel M Gelfand